Cap colors, label colors, and outdated language can be easily confused. Continue to carefully check vial labels to ensure that the intended product is administered. See below for Pfizer and Moderna labels that may cause confusion.
Pfizer Labels
myCAvax Release 30
Release 30 will go live September 15, 2022. Please stay tuned for additional details.
The myCAvax team is always looking for feedback on how to better improve the myCAvax experience. If you have feedback or suggestions for future improvements, please complete the survey here.
15-Minute Post-Vaccination Observation Period Update
The 15-minute post-vaccination observation period is now optional. COVID-19 vaccine Providers, particularly when vaccinating adolescents, should consider observing vaccine recipients for 15 minutes. For further information, including considerations for 30-minute observation periods, please see CDC Interim Clinical Considerations for Use of COVID-19 Vaccines.
Provider FAQ of the Week
Q: How long after COVID-19 illness can people receive COVID-19 vaccination?
A: People with known current SARS-CoV-2 infection should defer any COVID-19 vaccination, including booster vaccination, at least until recovery from the acute illness (if symptoms were present) and criteria to discontinue isolation have been met. People who recently had SARS-CoV-2 infection may consider delaying a primary series dose or booster dose by 3 months from symptom onset or positive test (if infection was asymptomatic). For further information, please see CDC Interim Clinical Considerations for Use of COVID-19 Vaccines.
Full list of Provider FAQs, updated weekly
